Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on

SIMPLE SUMMARY: Prostate cancer is the second most common cancer in men world-wide, with nearly 1.3 million new cases each year, and over the next twenty years the incidence and death rate are predicted to nearly double. For decades, this lethal disease has been more or less successfully treated usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Estébanez-Perpiñá, Eva, Bevan, Charlotte L., McEwan, Iain J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865914/
https://www.ncbi.nlm.nih.gov/pubmed/33572755
http://dx.doi.org/10.3390/cancers13030509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865914/
https://www.ncbi.nlm.nih.gov/pubmed/33572755
http://dx.doi.org/10.3390/cancers13030509

Ejemplares similares